Status: Recruiting
Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
Combination therapy of rosuvastatin 5mg and ezetimibe 10 mg showed similar achievement rate in decreasing LDL cholesterol level by 50% as single use of rosuvastatin 20 mg. This trial aims to prove non-inferiority of concomitant usage of low dose rosuvastatin and ezetimibe among patients with acute myocardial infarction who went through percutaneous coronary intervention at decreasing major adverse cardiac events compared to the efficacy of single use of high dose rosuvastatin.
Participants needed: 3,548
Trial details
Phase: Phase 4Age: 19+Biological sex: AllType: InterventionalSponsor: Kiyuk Chang, MD,PhDUpdated: Jul 30, 2025Locations: 7
Eligibility criteria
Adults Aged 19 and up [+3]
Patients with life expectancy of a year or less due to malignancy [+7]